306 related articles for article (PubMed ID: 31959131)
1. IL-1-conferred gene expression pattern in ERα
Nawas AF; Kanchwala M; Thomas-Jardin SE; Dahl H; Daescu K; Bautista M; Anunobi V; Wong A; Meade R; Mistry R; Ghatwai N; Bayerl F; Xing C; Delk NA
BMC Cancer; 2020 Jan; 20(1):46. PubMed ID: 31959131
[TBL] [Abstract][Full Text] [Related]
2. IL-1β induces p62/SQSTM1 and represses androgen receptor expression in prostate cancer cells.
Chang MA; Patel V; Gwede M; Morgado M; Tomasevich K; Fong EL; Farach-Carson MC; Delk NA
J Cell Biochem; 2014 Dec; 115(12):2188-97. PubMed ID: 25103771
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-135b regulates ERα, AR and HIF1AN and affects breast and prostate cancer cell growth.
Aakula A; Leivonen SK; Hintsanen P; Aittokallio T; Ceder Y; Børresen-Dale AL; Perälä M; Östling P; Kallioniemi O
Mol Oncol; 2015 Aug; 9(7):1287-300. PubMed ID: 25907805
[TBL] [Abstract][Full Text] [Related]
4. Chronic IL-1 exposure drives LNCaP cells to evolve androgen and AR independence.
Dahl HC; Kanchwala M; Thomas-Jardin SE; Sandhu A; Kanumuri P; Nawas AF; Xing C; Lin C; Frigo DE; Delk NA
PLoS One; 2020; 15(12):e0242970. PubMed ID: 33326447
[TBL] [Abstract][Full Text] [Related]
5. Identification of an IL-1-induced gene expression pattern in AR
Thomas-Jardin SE; Kanchwala MS; Jacob J; Merchant S; Meade RK; Gahnim NM; Nawas AF; Xing C; Delk NA
Prostate; 2018 Jun; 78(8):595-606. PubMed ID: 29527701
[TBL] [Abstract][Full Text] [Related]
6. RELA is sufficient to mediate interleukin-1 repression of androgen receptor expression and activity in an LNCaP disease progression model.
Thomas-Jardin SE; Dahl H; Kanchwala MS; Ha F; Jacob J; Soundharrajan R; Bautista M; Nawas AF; Robichaux D; Mistry R; Anunobi V; Xing C; Delk NA
Prostate; 2020 Feb; 80(2):133-145. PubMed ID: 31730277
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ERα-positive breast cancer.
Ciupek A; Rechoum Y; Gu G; Gelsomino L; Beyer AR; Brusco L; Covington KR; Tsimelzon A; Fuqua SA
Breast Cancer Res Treat; 2015 Nov; 154(2):225-37. PubMed ID: 26487496
[TBL] [Abstract][Full Text] [Related]
8. IL-1 induces p62/SQSTM1 and autophagy in ERα
Nawas AF; Mistry R; Narayanan S; Thomas-Jardin SE; Ramachandran J; Ravichandran J; Neduvelil E; Luangpanh K; Delk NA
J Cell Biochem; 2019 Feb; 120(2):1477-1491. PubMed ID: 30324661
[TBL] [Abstract][Full Text] [Related]
9. Targeting the androgen receptor in prostate and breast cancer: several new agents in development.
Proverbs-Singh T; Feldman JL; Morris MJ; Autio KA; Traina TA
Endocr Relat Cancer; 2015 Jun; 22(3):R87-R106. PubMed ID: 25722318
[TBL] [Abstract][Full Text] [Related]
10. miR-190 enhances endocrine therapy sensitivity by regulating SOX9 expression in breast cancer.
Yu Y; Yin W; Yu ZH; Zhou YJ; Chi JR; Ge J; Cao XC
J Exp Clin Cancer Res; 2019 Jan; 38(1):22. PubMed ID: 30658681
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor and estrogen receptor variants in prostate and breast cancers.
Valentín López JC; Lange CA; Dehm SM
J Steroid Biochem Mol Biol; 2024 Jul; 241():106522. PubMed ID: 38641298
[TBL] [Abstract][Full Text] [Related]
12. ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer.
Cai C; Wang H; He HH; Chen S; He L; Ma F; Mucci L; Wang Q; Fiore C; Sowalsky AG; Loda M; Liu XS; Brown M; Balk SP; Yuan X
J Clin Invest; 2013 Mar; 123(3):1109-22. PubMed ID: 23426182
[TBL] [Abstract][Full Text] [Related]
13. Modulation of androgen receptor signaling in hormonal therapy-resistant prostate cancer cell lines.
Marques RB; Dits NF; Erkens-Schulze S; van Ijcken WF; van Weerden WM; Jenster G
PLoS One; 2011; 6(8):e23144. PubMed ID: 21829708
[TBL] [Abstract][Full Text] [Related]
14. Independence of HIF1a and androgen signaling pathways in prostate cancer.
Tran MGB; Bibby BAS; Yang L; Lo F; Warren AY; Shukla D; Osborne M; Hadfield J; Carroll T; Stark R; Scott H; Ramos-Montoya A; Massie C; Maxwell P; West CML; Mills IG; Neal DE
BMC Cancer; 2020 May; 20(1):469. PubMed ID: 32450824
[TBL] [Abstract][Full Text] [Related]
15. Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis.
Neuwirt H; Bouchal J; Kharaishvili G; Ploner C; Jöhrer K; Pitterl F; Weber A; Klocker H; Eder IE
Cell Commun Signal; 2020 Jan; 18(1):11. PubMed ID: 31980029
[TBL] [Abstract][Full Text] [Related]
16. Constitutively active androgen receptor supports the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer.
Bahnassy S; Thangavel H; Quttina M; Khan AF; Dhanyalayam D; Ritho J; Karami S; Ren J; Bawa-Khalfe T
Cell Commun Signal; 2020 Sep; 18(1):154. PubMed ID: 32948192
[TBL] [Abstract][Full Text] [Related]
17. FGFR2-triggered autophagy and activation of Nrf-2 reduce breast cancer cell response to anti-ER drugs.
Gorska-Arcisz M; Popeda M; Braun M; Piasecka D; Nowak JI; Kitowska K; Stasilojc G; Okroj M; Romanska HM; Sadej R
Cell Mol Biol Lett; 2024 May; 29(1):71. PubMed ID: 38745155
[TBL] [Abstract][Full Text] [Related]
18. p62/SQSTM1 is required for cell survival of apoptosis-resistant bone metastatic prostate cancer cell lines.
Chang MA; Morgado M; Warren CR; Hinton CV; Farach-Carson MC; Delk NA
Prostate; 2014 Feb; 74(2):149-63. PubMed ID: 24122957
[TBL] [Abstract][Full Text] [Related]
19. Choline Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic Target.
Asim M; Massie CE; Orafidiya F; Pértega-Gomes N; Warren AY; Esmaeili M; Selth LA; Zecchini HI; Luko K; Qureshi A; Baridi A; Menon S; Madhu B; Escriu C; Lyons S; Vowler SL; Zecchini VR; Shaw G; Hessenkemper W; Russell R; Mohammed H; Stefanos N; Lynch AG; Grigorenko E; D'Santos C; Taylor C; Lamb A; Sriranjan R; Yang J; Stark R; Dehm SM; Rennie PS; Carroll JS; Griffiths JR; Tavaré S; Mills IG; McEwan IJ; Baniahmad A; Tilley WD; Neal DE
J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26657335
[TBL] [Abstract][Full Text] [Related]
20. The selective inhibitory effect of a synthetic tanshinone derivative on prostate cancer cells.
Xu D; Lin TH; Zhang C; Tsai YC; Li S; Zhang J; Yin M; Yeh S; Chang C
Prostate; 2012 May; 72(7):803-16. PubMed ID: 21932429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
